Page 2 - Efficacy Trial News Today

Press release content from PR Newswire. The AP news staff was not involved in its creation.

DJ Aura Biosciences Presents Interim Phase 2 Safety Data Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma at the ASRS 2021 Annual Meeting Arix Bioscience

Stay current on FDA drug approvals in 2021

June 29, 2021 GSK Singapore has signed an Advance Purchase Agreement with the Government of Singapore for sotrovimab Sotrovimab is currently undergoing review by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization Announcement follows the emergency use authorization (EUA) granted to sotrovimab by the US Food and Drug Administration (FDA) and a positive scientific opinion by the European Medicines Agencys (EMA) Committee for Me...

Natera Inc (NASDAQ: NTRA)Cassava Sciences Inc First, we have the clinical-stage biopharmaceutical company, Cassava. The company focuses on developing drugs for the treatment of nervous system disorders. Cassava is currently in focus due to the spotlight on the treatment of Alzheimer’s disease. This comes after Biogen Inc (NASDAQ: BIIB) received an accelerated FDA approval for its drug ADUHELM™. So, investors appear to be optimistic that Cassava’s simufilam and SavaDx may benefit ...

FDA approves investigational monoclonal antibody therapy sotrovimab for COVID-19 The U.S. Food and Drug Administration (FDA) has given the green light on the investigational monoclonal antibody therapy, sotrovimab, as a treatment for coronavirus disease 2019 (COVID-19). The regulatory agency granted an Emergency Use Authorization (EUA) for sotrovimab, previously called VIR-7831, to treat mild to moderate COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The thera...

Monoclonal antibodies are lab-made proteins, which start fighting the virus right away

Sotrovimab offers the prospect of reducing hospitalisation, fatalities.

27.05.2021 - Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) ... Seite 1

Long Bets is a philanthropic website built with funds from Amazon billionaire Jeff Bezos. Anyone can post a prediction and a challenge the winner donates the money to charity. Lord Rees, the prominent British astronomer, placed a bet in 2017 that “bioterror or bioerror will lead to one million casualties in a single event within a six-month period starting no later than December 31, 2020.” His friend and Harvard psychologist Steven Pinker took up the wager and lost. All bets are off as the ...